Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Charles

Showing results (381-390 of 519) with videos related to

Pageof 52
Sort By:
Breast Cancer Research and Treatment|December 9, 2025
Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancerKaren Page, Luke J Martinson, Robert K Hastings, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|March 1, 2026
Towards Meaningful Consumer and Community Involvement in Health Research: A Qualitative Study of Consumer and Researcher ExperiencesKimberley A Baxter, Jennifer Muller, David A Copland, et al.
Chemmedchem|January 27, 2018
Corrigendum: Inhibitor Selectivity for Cyclin-Dependent Kinase 7: A Structural, Thermodynamic, and Modelling StudyPascale Hazel, Sebastian H B Kroll, Alexander Bondke, et al.
Chemmedchem|January 27, 2017
Inhibitor Selectivity for Cyclin-Dependent Kinase 7: A Structural, Thermodynamic, and Modelling StudyPascale Hazel, Sebastian H B Kroll, Alexander Bondke, et al.
Molecular Cancer Therapeutics|March 2, 2026
Expression of Concern: SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2Barrie Peck, Chun-Yuan Chen, Ka-Kei Ho, et al.
Plos One|September 19, 2025
Molecular basis for the activation of the bitter taste receptor TAS2R14 by RitonavirJiao Wen, Xinyi Ma, Xinyi Zhou, et al.
Breast Cancer Research and Treatment|August 24, 2010
Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane StudyRobert E Coleman, Linda M Banks, Samia I Girgis, et al.
Oncotarget|June 21, 2015
DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activationMonica Faronato, Van T M Nguyen, Darren K Patten, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2026
Ten-year outcomes for image-guided moderately hypofractionated proton therapy for prostate cancerRandal H Henderson, Curtis M Bryant, R Charles Nichols, et al.
The Journal of Biological Chemistry|November 24, 2004
ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell lineRana Varshochi, Faezah Halim, Andrew Sunters, et al.
Pageof 52

Showing results (381-390 of 519) with videos related to

Sort By:
Pageof 52
Breast Cancer Research and Treatment|December 9, 2025
Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancerKaren Page, Luke J Martinson, Robert K Hastings, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|March 1, 2026
Towards Meaningful Consumer and Community Involvement in Health Research: A Qualitative Study of Consumer and Researcher ExperiencesKimberley A Baxter, Jennifer Muller, David A Copland, et al.
Chemmedchem|January 27, 2018
Corrigendum: Inhibitor Selectivity for Cyclin-Dependent Kinase 7: A Structural, Thermodynamic, and Modelling StudyPascale Hazel, Sebastian H B Kroll, Alexander Bondke, et al.
Chemmedchem|January 27, 2017
Inhibitor Selectivity for Cyclin-Dependent Kinase 7: A Structural, Thermodynamic, and Modelling StudyPascale Hazel, Sebastian H B Kroll, Alexander Bondke, et al.
Molecular Cancer Therapeutics|March 2, 2026
Expression of Concern: SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2Barrie Peck, Chun-Yuan Chen, Ka-Kei Ho, et al.
Plos One|September 19, 2025
Molecular basis for the activation of the bitter taste receptor TAS2R14 by RitonavirJiao Wen, Xinyi Ma, Xinyi Zhou, et al.
Breast Cancer Research and Treatment|August 24, 2010
Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane StudyRobert E Coleman, Linda M Banks, Samia I Girgis, et al.
Oncotarget|June 21, 2015
DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activationMonica Faronato, Van T M Nguyen, Darren K Patten, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2026
Ten-year outcomes for image-guided moderately hypofractionated proton therapy for prostate cancerRandal H Henderson, Curtis M Bryant, R Charles Nichols, et al.
The Journal of Biological Chemistry|November 24, 2004
ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell lineRana Varshochi, Faezah Halim, Andrew Sunters, et al.
Pageof 52